It is a pharma private limited company based in Punjab, Punjab, India, established in 1995.
1995 | Punjab, Punjab, India | ActiveMefro Pharmaceuticals Pvt Ltd, a active private limited company, was established on 29 May 1995 in Punjab, Punjab, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232PB1995PTC016505. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Rajesh Chopra (Director), Gamini Chopra (Director). It holds ₹2.24 Cr open charges and ₹1.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at F 68 Phase 7Industrial Area S A S Nagar Mohali Distt Ropar, Punjab, Punjab.
U24232PB1995PTC016505
016505
29 May 1995
₹0.50 M
₹0.50 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Mefro Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Chopra | Director | 23 Oct 2000 | Current |
| Gamini Chopra | Director | 15 Feb 2001 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mefro Pharmaceuticals Pvt Ltd, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 104.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
Unlock access to Mefro Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹22,372,000.00
₹15,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jul 2020 | Others | ₹8.90 M | Open |
| 01 Sep 2014 | Icici Bank Limited | ₹1.00 Cr | Open |
| 15 Feb 2005 | State Bank Of India | ₹3.00 M | Open |
| 26 Aug 1996 | State Bank Of India | ₹0.47 M | Open |
| 24 Apr 2013 | India Infoline Finance Limited | ₹6.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Mefro Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mefro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mefro Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Mefro Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Mefro Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was documented.
The activity A charge with Others amounted to Rs. 8.90 M with Charge ID 100349121 was registered on 13 Jul 2020. was completed.
A charge with Icici Bank Limited amounted to Rs. 10.00 M with Charge ID 10522664 was registered on 01 Sep 2014. was recorded as a recent event.
A charge registered on 24 Apr 2013 via Charge ID 10430961 with India Infoline Finance Limited was fully satisfied on 31 Jul 2014. was recorded as a recent event.
A charge with India Infoline Finance Limited amounted to Rs. 6.00 M with Charge ID 10430961 was registered on 24 Apr 2013. was recorded as a recent event.
The CIN of Mefro Pharmaceuticals Pvt Ltd is U24232PB1995PTC016505.
Mefro Pharmaceuticals Pvt Ltd is headquartered at F 68 Phase 7Industrial Area S A S Nagar Mohali Distt Ropar, Punjab, Punjab.
Mefro Pharmaceuticals Pvt Ltd was incorporated on 29 May 1995.
The current directors of Mefro Pharmaceuticals Pvt Ltd are
The primary industry of Mefro Pharmaceuticals Pvt Ltd is Trade.
Mefro Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Mefro Pharmaceuticals Pvt Ltd is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Mefro Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX